Drug Type Small molecule drug |
Synonyms Cetaben sodium (USAN) |
Target |
Mechanism PKC inhibitors(Protein kinase C inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H39NO2 |
InChIKeyQXWKHSSBFQDQPR-UHFFFAOYSA-N |
CAS Registry55986-43-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03447 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperlipidemias | Phase 2 | US | - | |
Hyperlipidemias | Phase 2 | - | - |